In South East Europe, penalties for drug offences remain high, although some efforts are being made to reduce penalties for drug use and possession. More recently however, governments have responded to increasing levels of NPS use with strong law enforcement efforts. In parallel, the economic crisis has had a devastating effect on the availability of harm reduction programmes.
In 2016, countries in Europe reported a new record high of 9,138 overdose deaths. The EMCDDA believe that through evidence-based policy making and the use of innovative solutions that can identify risk and general awareness, intervention can actually reduce overdose events and fatalities
The CSIDP Conference will bring together civil society organisations, national and European policy makers and other stakeholders to discuss for the very first time the importance of civil society involvement in drug policy.
NGO Juventas believe that the system of support for young people who are using psychoactive substances is underdeveloped and it is crucial to adjust the services to their needs, to fight and reduce the stigma surrounding young people who need help.
Eurasian Key Populations Health Network opens request for proposals for 2018 Small grants program "Gender and HIV" in order to improve health, inclusion and social wellbeing for Key Populations in Eastern European and Central Asian.
AFEW highlights their work in Eastern Europe and Central Asia which connects private groups and NGOs with public health care programs in order to treat people suffering from diseases through communication and collaboration that prioritises local communities and their care.
EMCDDA suggests new psychoactive drug usage is rapidly growing in prisons and may be causing further drug problems in federal facilities, a phenomenon in need of a widespread response by communities and policymakers.